EOS-215

N/A

Report date: 2025/08/13 20:02:02

Base Information

Drug NameEOS-215
Drug Alias NameEOS-215EOS-006215
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTriggering receptor expressed on myeloid cells 2 inhibitors
TargetsTriggering receptor expressed on myeloid cells 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesITeos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesITeos Therapeutics Inc
Inactive CompaniesiTeos Belgium SA
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A